Fatal familial insomnia: clinical features and molecular genetics

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Fatal familial insomnia (FFI) is a rare, autosomal dominant prion disease.
• It is characterized by progressive insomnia, autonomic dysfunction, and motor deficits.
• Pathologically, FFI involves selective degeneration of thalamic nuclei.

Purpose of the Study:

• To elucidate the genetic basis and clinicopathological features of Fatal familial insomnia.
• To understand the relationship between PRNP gene mutations, codon 129 polymorphism, and disease phenotype.
• To investigate the structural and functional consequences of thalamocortical limbic circuit damage in FFI.

Main Methods:

• Genetic analysis of the prion protein gene (PRNP) including codon 178 mutation and codon 129 polymorphism.
• Clinical assessment of patient symptoms, including sleep, autonomic, and motor functions.
• Pathological examination of brain tissue to determine the distribution and severity of lesions.

Main Results:

• FFI is linked to a PRNP missense mutation at codon 178, particularly when associated with methionine at codon 129.
• Homozygosity at codon 129 (Met/Met) leads to a shorter disease course, prominent sleep/autonomic disturbances, and thalamus-restricted pathology.
• Heterozygosity at codon 129 (Met/Val) results in a longer disease course, ataxia/dysarthria, and widespread lesions including the cerebral cortex.
• Limbic structures (thalamus, cingulate gyrus, orbitofrontal cortex) are consistently and severely affected.
• FFI selectively damages thalamocortical limbic structures, disrupting sleep-wake cycle and homeostasis.

Conclusions:

• FFI is a prion disease characterized by selective thalamocortical limbic degeneration.
• The PRNP codon 129 polymorphism significantly modulates the clinical and pathological phenotype of FFI.
• Damage to thalamocortical limbic circuits underlies the characteristic sleep, autonomic, and homeostatic disturbances in FFI.